NAM
MLAB icon

Nexpoint Asset Management’s Mesa Laboratories MLAB Stock Holding History

Nexpoint Asset Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,300
Closed -$755K – 196
2021
Q4 		$755K Buy
+2,300
New +$722K 0.11% 104

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nexpoint Asset Management's MLAB Position: Q1 2022 in Review

Nexpoint Asset Management sold out of Mesa Laboratories (MLAB) in Q1 2022, closing a stake of 2,300 shares — an estimated $755K sold.

Nexpoint Asset Management first reported a position in MLAB in Q4 2021 and held it in 1 quarter. The position peaked at $755K in Q4 2021. 175 funds tracked by Wall St. Rank hold MLAB as of Q1 2022.

  • Nexpoint Asset Management reported no remaining Mesa Laboratories position as of Q1 2022 after selling out during the quarter.
  • Nexpoint Asset Management sold 2,300 Mesa Laboratories shares in Q1 2022, an estimated $755K.
  • Nexpoint Asset Management first reported a position in Mesa Laboratories in Q4 2021 and held it in 1 quarter.
  • Nexpoint Asset Management's Mesa Laboratories position peaked at $755K in Q4 2021.
  • 175 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2022.

Based on Nexpoint Asset Management's 13F filing for Q1 2022, filed 16 May 2022.